Merck's free licensing of molnupiravir (to the Medicines Patent Pool, not WHO, by the way) will end when the pandemic is declared no longer an emergency by WHO. Considering how short patent terms are, this will probably be right at the end of its patent life anyway, of course. (I'm assuming WHO will be slow to un-declare an emergency, given that they're part of the notoriously dilatory United Nations.)

I think the weird "They're harming beagles!" freakout by some politicians is especially misguided because, as you mention, Leishmaniasis research can (and presumably will) also be used to protect dogs.

I just discovered two YouTube videos by medical researcher Susan Oliver (https://www.unsw.edu.au/staff/susan-oliver) explaining why ivermectin has not been shown to have value in treating COVID-19. Part 1 is here: https://youtu.be/-zWK_-4mfXs

Expand full comment